Eton Infringes Preterm Infant Drug Patents, Del. Judge Rules
A Delaware federal judge has ruled Eton Pharmaceuticals' planned generic version of infant supplement Elcys infringes three patents asserted in a suit lodged by rival Exela, determining that the disputed formulation...To view the full article, register now.
Already a subscriber? Click here to view full article